In the current work, we describe the mechanism of action of EGCG in T24 bladder cancer cells under the presence of IL-1β, which is demonstrated to inhibit tumor proliferation and uPAR upregulation. The gene discussed is IL1B; the disease is urinary bladder carcinoma.